Related Experiment Video
Updated: Apr 28, 2026

Palatable Western-style Cafeteria Diet as a Reliable Method for Modeling Diet-induced Obesity in Rodents
Published on: November 1, 2019
Is there a relationship between dietary MSG and [corrected] obesity in animals or humans?
John T Brosnan1, Adam Drewnowski, Mark I Friedman
1Department of Biochemistry, Memorial University of Newfoundland, St. John's, NL, A1B 3X9, Canada, jbrosnan@mun.ca.
Abstract:
The sodium salt of glutamate (monosodium glutamate; MSG) imparts a savory/meaty taste to foods, and has been used as a flavoring agent for millennia. Past research on MSG/glutamate has evaluated its physiologic, metabolic and behavioral actions, and its safety. Ingested MSG has been found to be safe, and to produce no remarkable effects, except on taste. However, some recent epidemiologic and animal studies have associated MSG use with obesity and aberrations in fat metabolism. Reported effects are usually attributed to direct actions of ingested MSG in brain. As these observations conflict with past MSG research findings, a symposium was convened at the 13th International Congress on Amino Acids, Peptides and Proteins to discuss them. The principal conclusions were: (1) the proposed link between MSG intake and weight gain is likely explained by co-varying environmental factors (e.g., diet, physical activity) linked to the "nutrition transition" in developing Asian countries. (2) Controlled intervention studies adding MSG to the diet of animals and humans show no effect on body weight. (3) Hypotheses positing dietary MSG effects on body weight involve results from rodent MSG injection studies that link MSG to actions in brain not applicable to MSG ingestion studies. The fundamental reason is that glutamate is metabolically compartmentalized in the body, and generally does not passively cross biologic membranes. Hence, almost no ingested glutamate/MSG passes from gut into blood, and essentially none transits placenta from maternal to fetal circulation, or crosses the blood-brain barrier. Dietary MSG, therefore, does not gain access to brain. Overall, it appears that normal dietary MSG use is unlikely to influence energy intake, body weight or fat metabolism.
Insights
Monosodium glutamate (MSG) is safe and does not cause weight gain or affect fat metabolism. Dietary MSG does not reach the brain because it is metabolized in the gut.
Area of Science:
- Food Science
- Nutritional Science
- Metabolic Research
Background:
- Monosodium glutamate (MSG) is a widely used food flavoring agent known for its savory taste.
- Past research established MSG safety and minimal physiological effects, primarily on taste.
- Recent studies suggest a link between MSG consumption and obesity/fat metabolism issues, often attributed to brain effects.
Purpose of the Study:
- To address conflicting findings on MSG's impact on weight and fat metabolism.
- To evaluate the scientific basis for claims linking dietary MSG to adverse health outcomes.
- To clarify the physiological fate of ingested MSG and its potential systemic effects.
Main Methods:
- A symposium reviewed existing epidemiologic, animal, and human intervention studies.
- Analysis focused on the metabolic pathways and bioavailability of ingested glutamate.
- Comparison of oral MSG ingestion versus direct injection studies in rodents was conducted.
Main Results:
- The proposed link between MSG intake and weight gain is likely due to confounding environmental factors associated with the "nutrition transition."
- Controlled dietary studies in animals and humans show no significant effect of MSG on body weight.
- Rodent studies involving MSG injection into the brain are not applicable to dietary MSG ingestion due to glutamate's metabolic compartmentalization.
Conclusions:
- Dietary MSG does not significantly cross biological barriers like the gut, placenta, or blood-brain barrier.
- Ingested glutamate is largely metabolized in the gut, preventing systemic access to the brain.
- Normal dietary intake of MSG is unlikely to influence energy intake, body weight, or fat metabolism.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Regulation of Food Intake
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

